915 abstracts found.



Results filter

Development of novel imaging methods in mouse cancer models

Year:

Session type:

Kevin Brindle1

1University of Cambridge, Cambridge, UK


Introduction: Integration between oncology and palliative care

Year:

Session type:

Irene Higginson1

1King’s College London, London, UK


CRAd improve gene replication efficiency and cancer killing effect of E1-deleted adenovirus including killing gene in head and neck cancer cell line

Year:

Session type:

Seon-Hui Shim, Myung-Whun Sung

Cancer Research Institute, Seoul, Republic Of Korea


Interactions between RhoA-GTPase and cGMP/cAMP ignalling influence both the vascular disrupting and anti-angiogenic activities of combretastatin A-4-Phosphate

Year:

Session type:

Chryso Kanthou, Gillian Tozer

University of Sheffield, UK


An in vitro study of the pro‑apoptotic properties of green tea polyphenols in neoplastic cell lines

Year:

Session type:

Lakshman Nalluri1, David Jamieson3, Trevor Jackson3, Lisa Lee-Jones2

1Northumbria University, Newcastle-upon-Tyne, UK, 2Manchester Metropolitan University, Manchester, UK, 3Newcastle University, Newcastle-upon-Tyne, UK


Wnt-11 promotes neuroendocrine-like differentiation, cell survival and migration in advanced prostate cancer

Year:

Session type:

Pinar Uysal-Onganer1, Soraya Diez1, Yoshiaki Kawano1, Siobhan Darrington1, Marjorie Walker1, Jonathan Waxman1, Robert Kypta2

1Imperial College London, London, UK, 2Centre for Cooperative Research in Biosciences, Bilbao, Spain


Second-line treatment of ovarian carcinoma with pegylated liposomal doxorubicin (Caelyx®)

Year:

Session type:

Richard Turkington, Paula Scullin, Joanne Millar

Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK


Identification of androgen receptor transcriptional complexes on distinct promoter targets

Year:

Session type:

Charlie Massie1, Falk Butter2, Andy Lynch1, Boris Adryan3, Nuno Barbosa-Morais1, Naomi Sharma1, Maxine Tran2, Matthias Mann1, David Neal1, Ian Mills1

1Cancer Research UK Cambridge Research Institute, University of Cambridge, UK, 2Max-Planck-Institute, Martinsried, Germany, 3Cambridge Systems Biology Centre, University of Cambridge, UK


Changes in Ca-125 relative to response following treatment with Pegylated Liposomal Doxorubicin (Caelyx®) in ovarian carcinoma

Year:

Session type:

Richard Turkington, Paula Scullin, Joanne Millar

Northern Ireland Cancer Centre, Belfast, Northern Ireland, UK


Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates Akt activation and potentiates mTOR blockade in breast cancer cells

Year:

Session type:

Matthew Roforth, Chalet Tan

Mercer University, Atlanta, USA


Page 1 of 921...25...Last »